|
Originally published In Press as doi:10.1074/jbc.M313178200 on January 14, 2004
J. Biol. Chem., Vol. 279, Issue 18, 18679-18687, April 30, 2004
Selective Expression and Functional Characteristics of Three Mammalian Hyaluronan Synthases in Oncogenic Malignant Transformation*
Naoki Itano ¶,
Takahiro Sawai ,
Fukiko Atsumi||,
Osamu Miyaishi**,
Shun'ichiro Taniguchi ,
Reiji Kannagi  ,
Michinari Hamaguchi ¶¶, and
Koji Kimata
From the
Institute for Molecular Science of Medicine, Aichi Medical University, Nagakute, Aichi 4801195, Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, the ||Laboratory Animal Research Center and **Second Department of Pathology, Aichi Medical University, Nagakute, Aichi 4801195, the  Department of Molecular Oncology and Angiology, Angio-Aging Division, Research Center on Aging and Adaptation, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621,  Program of Molecular Pathology, Aichi Cancer Center, Research Institute, Nagoya 464-8681, the ¶¶Department of Molecular Pathogenesis, Nagoya University School of Medicine, Showa-ku, Nagoya 466, Japan
Malignant transformation of fibroblasts and epithelial cells is often accompanied by increased hyaluronan production and accumulation. Despite recent progress in the study of hyaluronan biosynthesis, the mechanisms underlying the transformation-induced overproduction of hyaluronan have not been elucidated. Here we report that activity and transcriptional levels of hyaluronan synthase (HAS) significantly increased after oncogenic malignant transformation of a rat 3Y1 fibroblast cell line. Of three HAS isoforms (HAS1, HAS2, and HAS3), only HAS2 gene expression was increased in the v-Ha-ras transformed 3Y1 cells, which show less malignancy. In contrast, both HAS1 and HAS2 expressions were elevated in the highly malignant cells transformed with v-src and/or v-fos. To assess the contribution of HAS expression to the oncogenic malignant transformation, we established stable cell transfectants expressing sense and antisense HAS genes. Antisense suppression of the HAS2 expression significantly decreased hyaluronan production in the cells transformed by the oncogenic v-Ha-ras and eventually led to a reduction in tumorigenicity in the rat peritoneum. The introduction of the HAS1 and HAS2 genes promoted the growth of subcutaneous tumors in a manner dependent on the levels of hyaluronan synthesis. Significant growth promotion was observed within a wide range of HAS1 expression. In contrast, the growth stimulation was only seen within a narrow range of HAS2 expression, and high levels of HAS2 expression even inhibited tumor growth. These results suggest that proper regulation of the expression of each HAS isoform is required for optimal malignant transformation and tumor growth.
Received for publication, December 3, 2003
, and in revised form, January 9, 2004.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB097568 and AB097569.
* This study was supported by grants from the Core Research for Evolutional Science and Technology of the Japan Science and Technology Corporation, the preparatory grant for the research at the Division of Matrix Glycoconjugates, Research Center for Infectious Disease, Aichi Medical University, grants-in-aid for Young Scientists (B) and grants-in-aid for Scientific Research on Priority Areas from the Japan's Ministry of Education, Culture, Sports, Science and Technology, the Aichi Cancer Research Foundation, and special research funds from Seikagaku Corporation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 81-52-264-4811 (ext. 2095); Fax: 81-561-63-3532; E-mail: itano{at}amugw.aichi-med-u.ac.jp.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Ghosh, H. Kuppusamy, and L. M. Pilarski
Aberrant Splice Variants of HAS1 (Hyaluronan Synthase 1) Multimerize with and Modulate Normally Spliced HAS1 Protein: A POTENTIAL MECHANISM PROMOTING HUMAN CANCER
J. Biol. Chem.,
July 10, 2009;
284(28):
18840 - 18850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Bharadwaj, J. L. Kovar, E. Loughman, C. Elowsky, G. G. Oakley, and M. A. Simpson
Spontaneous Metastasis of Prostate Cancer Is Promoted by Excess Hyaluronan Synthesis and Processing
Am. J. Pathol.,
March 1, 2009;
174(3):
1027 - 1036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Adamia, A. A. Reichert, H. Kuppusamy, J. Kriangkum, A. Ghosh, J. J. Hodges, P. M. Pilarski, S. P. Treon, M. J. Mant, T. Reiman, et al.
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia
Blood,
December 15, 2008;
112(13):
5111 - 5121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Rilla, R. Tiihonen, A. Kultti, M. Tammi, and R. Tammi
Pericellular Hyaluronan Coat Visualized in Live Cells With a Fluorescent Probe Is Scaffolded by Plasma Membrane Protrusions
J. Histochem. Cytochem.,
October 1, 2008;
56(10):
901 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Itano
Simple Primary Structure, Complex Turnover Regulation and Multiple Roles of Hyaluronan
J. Biochem.,
August 1, 2008;
144(2):
131 - 137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Misra, L. M. Obeid, Y. A. Hannun, S. Minamisawa, F. G. Berger, R. R. Markwald, B. P. Toole, and S. Ghatak
Hyaluronan Constitutively Regulates Activation of COX-2-mediated Cell Survival Activity in Intestinal Epithelial and Colon Carcinoma Cells
J. Biol. Chem.,
May 23, 2008;
283(21):
14335 - 14344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Golshani, L. Lopez, V. Estrella, M. Kramer, N. Iida, and V. B. Lokeshwar
Hyaluronic Acid Synthase-1 Expression Regulates Bladder Cancer Growth, Invasion, and Angiogenesis through CD44
Cancer Res.,
January 15, 2008;
68(2):
483 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Koyama, N. Kobayashi, M. Harada, M. Takeoka, Y. Kawai, K. Sano, M. Fujimori, J. Amano, T. Ohhashi, R. Kannagi, et al.
Significance of Tumor-Associated Stroma in Promotion of Intratumoral Lymphangiogenesis: Pivotal Role of a Hyaluronan-Rich Tumor Microenvironment
Am. J. Pathol.,
January 1, 2008;
172(1):
179 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Choudhary, X. Zhang, P. Stojkovic, L. Hyslop, G. Anyfantis, M. Herbert, A. P. Murdoch, M. Stojkovic, and M. Lako
Putative Role of Hyaluronan and Its Related Genes, HAS2 and RHAMM, in Human Early Preimplantation Embryogenesis and Embryonic Stem Cell Characterization
Stem Cells,
December 1, 2007;
25(12):
3045 - 3057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Bharadwaj, K. Rector, and M. A. Simpson
Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis
J. Biol. Chem.,
July 13, 2007;
282(28):
20561 - 20572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Koyama, T. Hibi, Z. Isogai, M. Yoneda, M. Fujimori, J. Amano, M. Kawakubo, R. Kannagi, K. Kimata, S. Taniguchi, et al.
Hyperproduction of Hyaluronan in Neu-Induced Mammary Tumor Accelerates Angiogenesis through Stromal Cell Recruitment: Possible Involvement of Versican/PG-M
Am. J. Pathol.,
March 1, 2007;
170(3):
1086 - 1099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Misra, B. P. Toole, and S. Ghatak
Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells
J. Biol. Chem.,
November 17, 2006;
281(46):
34936 - 34941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Yip, M. Smollich, and M. Gotte
Therapeutic value of glycosaminoglycans in cancer.
Mol. Cancer Ther.,
September 1, 2006;
5(9):
2139 - 2148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Simpson
Concurrent Expression of Hyaluronan Biosynthetic and Processing Enzymes Promotes Growth and Vascularization of Prostate Tumors in Mice
Am. J. Pathol.,
July 1, 2006;
169(1):
247 - 257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Lopez, T. D. Camenisch, M. V. Stevens, B. J. Sands, J. McDonald, and J. A. Schroeder
CD44 Attenuates Metastatic Invasion during Breast Cancer Progression
Cancer Res.,
August 1, 2005;
65(15):
6755 - 6763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Udabage, G. R. Brownlee, M. Waltham, T. Blick, E. C. Walker, P. Heldin, S. K. Nilsson, E. W. Thompson, and T. J. Brown
Antisense-Mediated Suppression of Hyaluronan Synthase 2 Inhibits the Tumorigenesis and Progression of Breast Cancer
Cancer Res.,
July 15, 2005;
65(14):
6139 - 6150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Adamia, T. Reiman, M. Crainie, M. J. Mant, A. R. Belch, and L. M. Pilarski
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma
Blood,
June 15, 2005;
105(12):
4836 - 4844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Misra, S. Ghatak, and B. P. Toole
Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2
J. Biol. Chem.,
May 27, 2005;
280(21):
20310 - 20315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kakizaki, K. Kojima, K. Takagaki, M. Endo, R. Kannagi, M. Ito, Y. Maruo, H. Sato, T. Yasuda, S. Mita, et al.
A Novel Mechanism for the Inhibition of Hyaluronan Biosynthesis by 4-Methylumbelliferone
J. Biol. Chem.,
August 6, 2004;
279(32):
33281 - 33289.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|